🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Metastatic Bone Sarcoma

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125Phase 11 site📍 Chicago Ann & Robert H Lurie Children's Hospital of Chicago · Tests: Cytalux A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) NCT07193550Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Zanzalintinib Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites📍 Washington D.C.📍 Baltimore📍 Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Consolidative radiation therapy (cRT) Musculoskeletal Cancers Remote Monitoring and Care NCT07129226NA1 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Smart Watch PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) NCT06074692Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT) Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD146/HER2 CAR-T cells T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients. NCT06474676Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Cyclophosphamide, T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma NCT06827717Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: irinotecan liposome (II) + temozolomide + fluzoparib Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases NCT03965234Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Cisplatin, Isolated Chemotherapeutic Lung Perfusion, Metastasectomy Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma NCT07479732Phase 1, Phase 21 site📍 Beijing Peking University People's Hospital · Tests: Liposomal Irinotecan, Apatinib in arm1 Reduced Intensity Haploidentical BMT for High Risk Solid Tumors NCT01804634Phase 23 sites📍 Baltimore📍 The Bronx📍 Valhalla Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Cyclophosphamide, Fludarabine, low dose total body irradiation, Melphalan, Tacrolimus Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial NCT04693377NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Cryosurgery, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial NCT06114225Phase 21 site📍 Shanghai Ruijin Hospital · Tests: metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies NCT07197554Phase 16 sites📍 Duarte📍 Newport Beach📍 Boston SEED Therapeutics, Inc. · Tests: ST-01156 A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites📍 Birmingham📍 Aurora📍 Washington D.C. Nationwide Children's Hospital · Tests: Cabozantinib XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma NCT06571734Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Echocardiography, Multigated Acquisition Scan, Zanzalintinib BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma NCT04072042Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Apatinib monotherapy Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes NCT07194044Phase 121 sites📍 Birmingham📍 Phoenix📍 Hartford H. Lee Moffitt Cancer Center and Research Institute · Tests: Vincristine, Doxorubicin, Cyclophosphamide, Ifosfamide, Actinomycin Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study NCT05019703Phase 22 sites📍 Boston📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas NCT03715933Phase 137 sites📍 Scottsdale📍 Beverly Hills📍 Duarte Inhibrx Biosciences, Inc · Tests: INBRX-109, Irinotecan, Temozolomide, carboplatin, pemetrexed Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer NCT07727434n/a1 site📍 Istanbul Istanbul University · Tests: Routine Diagnostic and Treatment Pathway Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse NCT07871864Phase 377 sites📍 Aarhus📍 Aarhus📍 Copenhagen Gustave Roussy, Cancer Campus, Grand Paris · Tests: Experimental group : Cabometyx ® 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (i… Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma NCT05235165Phase 3233 sites📍 Birmingham📍 Anchorage📍 Kingman Children's Oncology Group · Tests: Biospecimen Collection, Computed Tomography, Questionnaire Administration, Thoracoscopy, Thoracotomy A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma NCT07477457Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Methotrexate, Doxorubicin, Cisplatin, Gefitinib, Trametinib Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma NCT05726383Phase 22 sites📍 Hackensack📍 Houston Hackensack Meridian Health · Tests: Iscador*P
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy